| CAS No.: | 22503-72-6 |
|---|---|
| Formula: | C8h9cln2o2s |
| EINECS: | 1592732-453-0 |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Quality: | Crude |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
1. Product Basic Information
| Product name | IDRA 21 |
| CAS No. | 22503-72-6 |
| MF | C8H9ClN2O2S |
| MW | 232.69 |
| Melting point | 209 °C(Solv: acetic acid ) |
| Boiling point | 405.1±55.0 °C(Predicted) |
| Density | 1.394±0.06 g/cm3(Predicted) |
| Storage | Keep in dark place,Inert atmosphere,Room temperature |
IDRA-21 is classified as an ampakine. It is able to improve focus and attention as well as promote learning and memory. Ampakines are growing in popularity largely because they provide the cognitive benefits of stimulants without the undesirable side effects.
3. Product Benefits
IDRA-21's primary benefit is a dramatic improvement in learning and memory. It significantly outperformed aniracetam and is approximately 10-30x more potent at reversing cognitive deficits caused by scopolamine and al prazolam. In addition, IDRA-21 benefits lasts for up to three days after just one dose.
IDRA-21 is also thought to induce long-term potentiation (LTP). LTP is a long-lasting enhancement in how neurons communicate with in the brain [4]. It is vital for improving synaptic plasticity, which strengthens synapses within the brain. As synapses are largely responsible for memories, enhancing their strength and function is vital to improving overall cognition.
Our Product purity and quality is guaranteed by lab test for each batch
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}